These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Important determinants of bone strength: beyond bone mineral density. Friedman AW J Clin Rheumatol; 2006 Apr; 12(2):70-7. PubMed ID: 16601540 [TBL] [Abstract][Full Text] [Related]
23. The quality of bone: a "magic natural alloy". Maggi S; Lauretani F; Ferrucci L; Gallina P; Bianchi D; Marzari C; Noale M; Crepaldi G Aging Clin Exp Res; 2004 Jun; 16 Suppl(3):3-9. PubMed ID: 15506693 [No Abstract] [Full Text] [Related]
24. Impact of phytochemicals on maintaining bone and joint health. Hunter DC; Skinner MA; Lister CE Nutrition; 2008 Apr; 24(4):390-2. PubMed ID: 18280702 [No Abstract] [Full Text] [Related]
25. Aging bone and cartilage: cross-cutting issues. Carrington JL Biochem Biophys Res Commun; 2005 Mar; 328(3):700-8. PubMed ID: 15694404 [TBL] [Abstract][Full Text] [Related]
26. Bone quality fills holes in fracture risk. Stokstad E Science; 2005 Jun; 308(5728):1580. PubMed ID: 15947173 [No Abstract] [Full Text] [Related]
27. The spinal osteoporoses. Mechanisms of pathogenesis and pathophysiology. Frost HM Clin Endocrinol Metab; 1973 Jul; 2(2):257-75. PubMed ID: 4548005 [No Abstract] [Full Text] [Related]
28. [Arterial circulatory modifications in aseptic necrosis of the hip and in epiphysiolysis]. Jung A; Wurtz JP; Randrianarivo P Mem Acad Chir (Paris); 1965 May; 91(15):489-506. PubMed ID: 5834584 [No Abstract] [Full Text] [Related]
29. [Effect of physical activity and inactivity on bones and joints]. Videman T; Lindholm S Duodecim; 1983; 99(1):44-8. PubMed ID: 6347624 [No Abstract] [Full Text] [Related]
30. Bone ultrastructure: evolution during osteoporosis and aging. Laurent Benhamou C Osteoporos Int; 2009 Jun; 20(6):1085-7. PubMed ID: 19340498 [No Abstract] [Full Text] [Related]
31. Anatomy and physiology; the development and growth of bones and joints. GARDNER E Instr Course Lect; 1956; 13():235-46. PubMed ID: 13415721 [No Abstract] [Full Text] [Related]
32. The role of growth hormone in glucocorticoid-induced osteoporosis. Lombardi G; Colarusso S; Di Somma C; Guerra E; Tauchmanova L; Colao A J Endocrinol Invest; 2008 Jul; 31(7 Suppl):38-42. PubMed ID: 18791350 [TBL] [Abstract][Full Text] [Related]
33. Bone tissue mechanisms underlying osteoporoses. Courpron P Orthop Clin North Am; 1981 Jul; 12(3):513-45. PubMed ID: 7027113 [No Abstract] [Full Text] [Related]
34. [Functional muscle changes in patients with cervicothoracic osteochondrosis]. Diurianova I; Turzova E Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):368-74. PubMed ID: 6720177 [TBL] [Abstract][Full Text] [Related]
35. [Underwater tractions as a part of the complex therapy of spinal osteochondrosis]. Miriutova NF; Rekhtina AN; Vesner VE; Galakhov NN Vopr Kurortol Fizioter Lech Fiz Kult; 2004; (3):24-8. PubMed ID: 15216787 [No Abstract] [Full Text] [Related]
36. Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone. Nampei A; Hashimoto J; Hayashida K; Tsuboi H; Shi K; Tsuji I; Miyashita H; Yamada T; Matsukawa N; Matsumoto M; Morimoto S; Ogihara T; Ochi T; Yoshikawa H J Bone Miner Metab; 2004; 22(3):176-84. PubMed ID: 15108058 [TBL] [Abstract][Full Text] [Related]
37. [OSTEOARTICULAR MANIFESTATIONS IN ENDOCRINE DISEASES]. BALACEANU M Med Interna (Bucur); 1963 Jul; 15():777-83. PubMed ID: 14056031 [No Abstract] [Full Text] [Related]
38. [Aging of bone tissue]. Orlova EV Med Sestra; 1983 Jan; 42(1):34-8. PubMed ID: 6550163 [No Abstract] [Full Text] [Related]